Showing results (131-140 of 178) with videos related to
Sort By:
Pageof 18
Annals of Medicine|May 25, 2006
Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI)Juha Lund, Qiu-Ping Qin, Tuomo Ilva, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|November 25, 2010
Studies on the effects of heparin products on pregnancy-associated plasma protein ASaara Wittfooth, Risto Tertti, Mauri Lepäntalo, et al.Clinical Biochemistry|February 9, 2013
Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimensRiina-Minna Väänänen, Hans Lilja, Angel Cronin, et al.European Urology|February 16, 2015
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control StudyPär Stattin, Andrew J Vickers, Daniel D Sjoberg, et al.The Prostate|September 21, 2004
Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissueThomas Steuber, Pauliina Niemela, Alexander Haese, et al.Analytical and Bioanalytical Chemistry|November 24, 2020
Upconverting nanoparticle reporter-based highly sensitive rapid lateral flow immunoassay for hepatitis B virus surface antigenIida Martiskainen, Sheikh M Talha, Karoliina Vuorenpää, et al.Communications Biology|August 23, 2020
Glycovariant-based lateral flow immunoassay to detect ovarian cancer-associated serum CA125Sherif Bayoumy, Heidi Hyytiä, Janne Leivo, et al.Journal of Cardiac Failure|August 2, 2008
Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathyKati H Miettinen, Susann Eriksson, Jarkko Magga, et al.Gynecologic Oncology|January 1, 2020
A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancerLiina Salminen, Nimrah Nadeem, Shruti Jain, et al.European Journal of Epidemiology|August 2, 2017
A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationaleAnssi Auvinen, Antti Rannikko, Kimmo Taari, et al.Pageof 18